Web page content
Bovilis IBR marker inac - Data sheet
Bovilis IBR marker inac
Description
Bovilis IBR marker is an inactivated marker vaccine containing per dose at least 60 ELISA units for induction of 6.1 - 11.1 log2 VN-units in mouse potency test of gE- BoHV-1 strain GK/D.
Indication
Bovine herpesvirus type 1 (BoHV-1) the causative agent of infectious bovine rhinotracheitis (IBR). Bovilis IBR marker inac is for active immunisation of cattle to reduce the intensity and duration of clinical signs (pyrexia) induced by an infection with BoHV-1 as well as to reduce the replication and nasal excretion of the field virus
Dosage and administration
Intramuscular injection, 2 ml per animal.
All cattle can be vaccinated from an age of three months onwards.
- Basic vaccination:
Two inoculations with an interval of 4 weeks. - Re-vaccination (after basic vaccination with Bovilis IBR marker inac or with the live Intervet BoHV-1 marker vaccine):
One inoculation every 6 months.
Side effects
No clinical reactions. Occasionally a hypersensitivity reaction may occur. In such cases an appropriate symptomatic treatment should be administered. At the injection site a local reaction may occur.
Withdrawal period
None
Notes
The vaccine does not elicit antibodies to glycoprotein E of BoHV-1 (marker vaccine). This enables discrimination between cattle vaccinated with the product and cattle infected with BoHV 1 field virus.
Additional information
Use before expiry date printed on the pack.
Storage
Store dark at 2-8°C. Do not freeze.
Presentation
Hydrolytical glass type I (PhEur) or polyethylene-terephthalate (PET) vials with 5, 10, 25, 50 or 100 doses
Top of page
Contact form
Ask the expert
Print
Print text
Bookmark
Color
b & w
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none)%3B){kind=small}
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none)%3B){kind=small}